On Mar. 18, 2021, AstraZeneca announced that the Medicines and Healthcare products Regulatory Agency (MHRA) and European Medicines Agency (EMA) had reaffirmed the benefits of COVID-19 Vaccine AstraZeneca continue to far outweigh the risks.